Literature DB >> 31852637

[Development and applications of CRISPR/Cas9 library screening technology in cancer research].

Ting Lei1,2, Bin Xiao1, Yongyin He1,2, Jing Qu1, Zhaohui Sun1, Linhai Li1.   

Abstract

The CRISPR/Cas9 technology has developed rapidly in recent years with fast, simple and accurate editing functions to allow gene knockout, knock in, activation and interference. It has become a powerful genetic screening tool and been widely used in various models including cell lines, mice and zebrafish. The application of CRISPR system in constructing genome library for high-throughput screening is the main strategy for target gene research of diseases, especially neoplasms. Here we summarize the rationales and recent development of CRISPR/Cas9 library screening technology, the strategies for improving the off-target effects, the basic workflow of library screening and the application of this technology in tumor research.

Entities:  

Keywords:  CRISPR/Cas9; high-throughput screening; library; tumor

Mesh:

Year:  2019        PMID: 31852637      PMCID: PMC6926087          DOI: 10.12122/j.issn.1673-4254.2019.11.18

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  41 in total

1.  Identification of genes that are associated with DNA repeats in prokaryotes.

Authors:  Ruud Jansen; Jan D A van Embden; Wim Gaastra; Leo M Schouls
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

2.  Identification and characterization of essential genes in the human genome.

Authors:  Tim Wang; Kıvanç Birsoy; Nicholas W Hughes; Kevin M Krupczak; Yorick Post; Jenny J Wei; Eric S Lander; David M Sabatini
Journal:  Science       Date:  2015-10-15       Impact factor: 47.728

3.  Generation of gene-modified mice via Cas9/RNA-mediated gene targeting.

Authors:  Bin Shen; Jun Zhang; Hongya Wu; Jianying Wang; Ke Ma; Zheng Li; Xueguang Zhang; Pumin Zhang; Xingxu Huang
Journal:  Cell Res       Date:  2013-04-02       Impact factor: 25.617

4.  Chinese scientists to pioneer first human CRISPR trial.

Authors:  David Cyranoski
Journal:  Nature       Date:  2016-07-28       Impact factor: 49.962

5.  Identification of essential genes for cancer immunotherapy.

Authors:  Shashank J Patel; Neville E Sanjana; Rigel J Kishton; Arash Eidizadeh; Suman K Vodnala; Maggie Cam; Jared J Gartner; Li Jia; Seth M Steinberg; Tori N Yamamoto; Anand S Merchant; Gautam U Mehta; Anna Chichura; Ophir Shalem; Eric Tran; Robert Eil; Madhusudhanan Sukumar; Eva Perez Guijarro; Chi-Ping Day; Paul Robbins; Steve Feldman; Glenn Merlino; Feng Zhang; Nicholas P Restifo
Journal:  Nature       Date:  2017-08-07       Impact factor: 49.962

6.  Improved vectors and genome-wide libraries for CRISPR screening.

Authors:  Neville E Sanjana; Ophir Shalem; Feng Zhang
Journal:  Nat Methods       Date:  2014-08       Impact factor: 28.547

7.  A high-throughput screening strategy for detecting CRISPR-Cas9 induced mutations using next-generation sequencing.

Authors:  Charles C Bell; Graham W Magor; Kevin R Gillinder; Andrew C Perkins
Journal:  BMC Genomics       Date:  2014-11-20       Impact factor: 3.969

8.  Potential mechanisms of resistance to venetoclax and strategies to circumvent it.

Authors:  Stephen K Tahir; Morey L Smith; Paul Hessler; Lisa Roberts Rapp; Kenneth B Idler; Chang H Park; Joel D Leverson; Lloyd T Lam
Journal:  BMC Cancer       Date:  2017-06-02       Impact factor: 4.430

9.  Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in TP53 wild-type Ewing sarcoma.

Authors:  Björn Stolte; Amanda Balboni Iniguez; Neekesh V Dharia; Amanda L Robichaud; Amy Saur Conway; Ann M Morgan; Gabriela Alexe; Nathan J Schauer; Xiaoxi Liu; Gregory H Bird; Aviad Tsherniak; Francisca Vazquez; Sara J Buhrlage; Loren D Walensky; Kimberly Stegmaier
Journal:  J Exp Med       Date:  2018-07-25       Impact factor: 14.307

10.  Cancer drug addiction is relayed by an ERK2-dependent phenotype switch.

Authors:  Xiangjun Kong; Thomas Kuilman; Aida Shahrabi; Julia Boshuizen; Kristel Kemper; Ji-Ying Song; Hans W M Niessen; Elisa A Rozeman; Marnix H Geukes Foppen; Christian U Blank; Daniel S Peeper
Journal:  Nature       Date:  2017-10-04       Impact factor: 49.962

View more
  1 in total

Review 1.  Advances in CRISPR/Cas9.

Authors:  Youmin Zhu
Journal:  Biomed Res Int       Date:  2022-09-23       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.